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Probe functionalization with a Rhop-3 antibody:
toward a Rhop-3 antigen immunosensor for detection
of malaria
Salaam Saleh & Susan Moreno-Molek & Indika Perera &
Alan Riga & Tobili Sam-Yellowe & Mekki Bayachou
Abstract The antibody specific for the malaria protein,
Rhop-3, and FL-Rhop-3, were immobilized on the surface
of a gold electrode modified with cysteamine. Colloidal
gold was used to enhance the detection signal for Rhop-3
antigens. The Rhop-3 antibody was also immobilized on
gold electrodes preactivated with dithiobis(succinimidyl
proprionate) (DSP). Immobilization was performed at room
temperature and at 37 °C. Cyclic voltammetry (CV) was
used to monitor the interaction between the immobilized
antibody and its cognate antigen in solution, using ferricy-
anide, K3Fe(CN)6, as reporting electroactive probe. Tests
indicate recognition of Rhop-3 protein by the immobilized
antibody. Antigen recognition was enhanced by incubation
at 37 °C compared with room-temperature incubation. Our
results suggest that an immunosensor can be developed and
optimized to aid detection of Rhop-3 antigens in samples
from malaria patients. As far as we are aware, this is the first
amperometric immunosensor targeting Rhop-3 antigen as a
malaria biomarker.
Keywords Immunosensor . Antibody immobilization .
Malaria diagnosis . Plasmodium falciparum . Rhop-3 . Rapid
diagnostic test
Introduction
Malaria is a disease caused by infection with protozoan
parasites of the genus Plasmodium. The parasites are trans-
mitted to humans by a mosquito vector of the genus Anoph
eles. Four species of Plasmodium parasites cause malaria in
humans, P. falciparum, P. vivax, P. malariae, and P. ovale. P.
falciparum and P. vivax cause the most infections world-
wide, with P. falciparum predominating in Africa and P.
vivax predominating in South America and Asia. P. falcipa
rum is also the cause of the most severe illnesses and deaths
[1]. Recent estimates suggest that 1 to 3 million deaths, and
515 million cases of malaria occur each year. Most malaria
deaths are children, with an alarming estimated average of
four children per minute. Malaria morbidity and mortality
remain significant in many parts of the world [1].
Current diagnostic methods for malaria include micros-
copy and immunologic rapid diagnostic tests (RDTs). Three
proteins are currently being tested for use in RDTs: P.
falciparum histidine-rich protein 2 (PfHRP2), P. falciparum
lactate dehydrogenase (PfLDH), and aldolase [2, 3].
Literature reports of P. falciparum geographic variants
that do not express PfHRP pose a challenge for the use of
current PfHRP-based RDTs for malaria diagnosis [4–6].
Improved methods for malaria diagnosis are required to
enable accurate diagnosis and effective early intervention
2379
and treatment of malaria. Antigen recognition by specific
antibodies forms the basis of immunosensors designed for
use in diagnosis of a broad range of infectious and chronic
diseases [7–9]. Immunosensors designed to detect specific
peptides, antigen epitopes, or antibodies are used for chronic
and infectious diseases [10]. Serological studies using sera
of malaria-infected individuals from different geographic
regions showed that the C-terminus of Rhop3 is structurally
conserved among different geographical and laboratory P.
falciparum isolates [11, 12]. Because of its involvement in
erythrocyte invasion, Rhop3 has been regarded as an ideal
candidate for a vaccine and for diagnostic studies.
The purpose of this study was to develop an immunosensor
capable of detecting Plasmodium antigens in patient samples.
An amperometric immunosensor for detection of PfHRP2 has
been shown to enable highly sensitive detection of anti-
PfHRP2 in human serum [13]. However, because of the
variations observed in PfHRP2 [4] and the absence of PfHRP2
in some geographic P. falciparum strains [5, 6, 14], there is a
need to identify other P. falciparum antigens that can serve as
important biomarkers for malaria diagnosis [2, 3].
In this communication, we report a first attempt to gen-
erate an immunosensor that can identify the Rhop-3 malaria
protein. An antibody specific for P. berghei Rhop-3 was
immobilized on gold electrodes by use of both cysteamine
and DSP linking strategies. Antigen recognition was opti-
mum at 37 °C.
Materials and methods
Recombinant proteins
The full length (FL) P. berghei Rhop-3 gene was amplified
by polymerase chain reaction (PCR), by use of primers
containing appropriate restriction sites, digested, and cloned
into pRSET (version A) (Invitrogen, San Diego, CA, USA),
using methods described elsewhere [15], to generate a fu-
sion protein containing a six-histidine tag. The plasmid
pRSETA was transformed into Escherichia coli strain
BL21.DE3. After culture at 37 °C until the OD600 was 0.7,
recombinant protein expression was induced by addition of
IPTG at a final concentration of 1 mmol L 1. Expressed
protein was detected by use of rabbit antibody 686 [12] and
western blotting. Antibody 686 is specific for P. falciparum
Rhop-3 [12]. The Coomassie blue SDS-PAGE gel obtained
from the purification scheme for the 100-kDa P. berghei
recombinant protein (His-FLPbRhop-3) is shown in Elec-
tronic Supplementary Material Fig. S1. The recombinant
full-length protein was purified by use of nickel-chelate
chromatography (Ni2+–NTA–agarose from Qiagen, Chats-
worth, CA, USA) under denaturing conditions using
8 mol L 1 urea. The recombinant protein, designated His-
FLPbRhop-3, from 10-L large-scale cultures was dialyzed
against 1XPBS with 0.1% Triton, concentrated using a high-
speed vacuum centrifuge (Savant Instruments, Holbrook,
NY, USA) and after protein estimation by use of the
Bradford method [16]. One milligram of FLPbRhop-3 was
obtained [15]. The recombinant protein FLPbRhop-3 was
used to produce monospecific polyclonal antibodies in
rabbits as described elsewhere [15]. Antibody specificity
to the FLPbRhop-3 recombinant protein was evaluated.
The antibody titers were determined and the reactivity of
the antibodies to native Rhop-3 in immunoelectron micros-
copy was obtained [15]. P. falciparum schizont extracts
were obtained by subjecting schizont pellets [17] to three
freeze–thaw cycles in 1× PBS. After centrifugation at
14,000g, supernatant containing schizont proteins was col-
lected in an Eppendorf tube for use in antibody binding by
western blotting.
Antibody immobilization
Antibody immobilization on gold electrodes (CH Instruments,
Austin, TX, USA) was performed by use of cysteamine–
glutaraldehyde chemistry [9] or dithiobis(succinimidyl propi-
onate) (DSP)-modified gold electrodes [18] in a preliminary
study to establish conditions for immobilization of Rhop-3-
specific antibodies. Incubation was performed at room tem-
perature or at 37 °C. A slightly modified method of glutaral-
dehyde covalent crosslinking was used [9]. Gold electrodes
were polished with alumina slurries for 10–15 min, sonicated,
rinsed with distilled water, and then cycled between 0 and
+1.6 Vat 100 mV s 1 in 0.1 mol L 1 H2SO4 solution to obtain
a stable background voltammogram. The electrodes were
incubated with 0.02 mol L 1 cysteamine aqueous solution
for 12 h then rinsed in water and incubated in 12% (v/v)
glutaraldehyde for 1 h. The resulting surface was rinsed with
water and incubated in cyteamine for another 12 h, followed
by washing with deionized water to remove any physically
adsorbed molecules. The electrodes were incubated in 1 mL
10-nm colloidal gold (Sigma Chemicals, St Louis, MO, USA)
for 10 h to form an enhancing layer of gold nanoparticles. The
added gold nanoparticles result in an increase in the density of
sites for antibody immobilization on the gold electrode. An
AFM image of early-stage immobilization of gold nanopar-
ticles on a highly oriented pyrolytic graphite substrate
(HOPG) grafted with linkers having free thiols that serve to
attach the gold nanoparticles, just as is the case on our gold
electrodes, is shown in Electronic Supplementary Material
Fig. S2.
In initial studies, we investigated the use of both rabbit
monospecific polyclonal antisera #686 [12] and mouse
monospecific polyclonal antisera FLRhop-3 specific for P.
falciparum and P. bergheii Rhop-3 proteins, respectively.
Specificity of FLRhop-3 antibody was confirmed by
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immunoassays, for example western blotting, immunofluores-
cence, and immunoprecipitation [15]. FLRhop-3 antibody
was shown to react with the 100-kDa Rhop-3 protein by
western blotting at a dilution of 1:1000 [15]. FLRhop-3 anti-
body reactivity with FLRhop-3 was evaluated in native immu-
noassays (immunoprecipiation and immunofluorescence).
Antibody dilutions of 1:10–1:1000 were used in immuno-
assays; native immunoprecipitation (1:10), western blotting,
and immunofluorescence (1:1000). On the basis of these
results a dilution of 1:50 was used for antibody immobiliza-
tion to gold electrodes in this initial study. Incubation times
and temperature were optimized for antibody immobilization
experiments. The methods presented here are for FLRhop-3
antibody only.
The modified electrodes were incubated in mouse anti-
sera FL-Rhop-3 diluted 1:50 in 1× PBS [15]. Gold electro-
des were incubated in antisera for 12 h, rinsed in 1× PBS,
and then immersed in 1 mg mL 1 bovine serum albumin
(BSA) for 1 h to block non-specific sites on the electrode
[9]. After washing in 1× PBS, the electrodes were stored at
4 °C before use in antigen recognition tests.
For modification with DSP chemistry, clean gold electro-
des were incubated in DSP solutions for 2 h, washed with
deionized water, and incubated with FLRhop-3 antisera
diluted 1:50, for 1 h. The electrodes were washed in 1×
PBS, blocked in 1 mg mL 1 BSA for 1 h, and washed again
in 1× PBS, followed by incubation in 6 μg mL 1 FLRhop-3
for 1 h. As a negative control, the DSP-modified electrodes
with immobilized FLRhop3 antibodies were incubated with
6 μg mL 1 chicken ovalbumin in lieu of the target antigen
for 1 h. The schematic workflow for the process of antibody
immobilization and antigen detection is shown in Fig. 1. In
this preliminary work, we used only recombinant proteins as
target antigen to establish conditions necessary for protein
detection with the immunosensor being developed. There-
fore, correlations of parasite densities with purified protein
levels were not performed. Such correlations will be inves-
tigated in future studies.
Voltammetry
Cyclic voltammetry was used to assess the efficiency of
antigen binding. Cyclic voltammetry was performed in a
three-electrode cell. All potentials reported are relative to
the Ag/AgCl reference system. The working electrode was
the modified gold electrode with a platinum wire serving as
the counter electrode. The potential window scanned was
between −0.2 and +0.6 V. Electrochemical analysis was
performed on the electrodes at various stages of the modi-
fication process, and before and after incubation with anti-
gen for 1 h to evaluate binding recognition efficiency.
In terms of its application to detection of Rhop-3 antigens
in this initial stage, the cyclic voltammetry method takes
advantage of changes of current generated by a freely dif-
fusing redox probe (ferricyanide in this case) to the under-
lying surface of the modified immunosensor. Binding of
bulky Rhop-3 target proteins on the surface is expected to
compromise the extent of access of the redox probe to the
underlying electrode. A decrease in current will then signal
and quantify binding of the target protein on the antibody
sites on the immunosensor. This explains the amperometric
detection of Rhop-3 in this initial work.
Results and discussion
Recognition proteins, for example antibodies, may be di-
rectly adsorbed on hydrophobic surfaces, for example elec-
trode interfaces. However, this usually leads to denaturation
and/or disruption of the recognition of the target protein.
Even when the native structure of the adsorbed antibody is
preserved, binding may be limited by steric hindrance of
recognition sites. In an effort to preserve Rhop-3 recognition
by antibodies, we took advantage of bifunctional linkers
such as β-mercaptoethylamine (cysteamine) or dithiobis
(succinimidyl propionate) (DSP) to provide point-covalent
binding to surface lysine residues on the antibody targeted
Fig. 1 Schematic
representation of electrode
modification with linker
(either DSP or cysteamine
glutaraldehyde) and 10 nm gold
nanoparticles (spheres). Anti
body is immobilized using
CHO (glutaraldehyde) or NHS
(DSP) chemistry before use
for antigen recognition
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for immobilization; a thiol group on the same linker served
for binding to the gold surface or to gold nanoparticles
(10 nm) on an underlying gold surface. The different steps
of antibody immobilization for both methods are shown in
Fig. 1. Figure 2 shows the typical electrode response at
different stages of the assay using the cysteamine–glutaral-
dehyde immobilization of anti-Rhop-3. First, the cysteamine
treatment introduces amino functionality on to the electrode
surface. Second, glutaraldehyde preactivation of the elec-
trode is performed to ensure subsequent multipoint attach-
ment of the recognition antibodies in question [19, 20].
Figure 2 shows that the voltammetric current decreases
upon immobilization of anti-FLRhop-3 on the cysteamine–
glutaraldehyde-preactivated electrode surface. The current
decrease is expected, because attachment of the bulky anti-
body molecules reduces access of the ferricyanide used as
reporting redox probe. Antigen recognition should normally
be accompanied by a further reduction of current as a result
of Rhop-3 proteins binding to the surface. Although there is
a small current decrease upon introduction of Rhop-3 target
molecules, the recorded current change is very minimal and
may not be attributed to specific recognition of Rhop-3
proteins. The immobilization of recognition proteins using
glutaraldehyde-preactivated surfaces is simple and efficient;
however, this method is also known to result in immobilized
proteins with lower recognition capability. In fact, potential
multipoint cross-linking may result in altered conforma-
tions, which can reduce recognition. The altered antibody
response may also be the result of changes in the microen-
vironment because of glutaraldehyde preactivation and/or a
non-uniform layer of immobilized antibodies.
In effort to improve Rhop-3 recognition by immobi-
lized antibodies, we investigated another immobilization
strategy, one that uses a molecular linker with a
preactivated end that targets single primary amines on
the surface of the antibody.
In this modified strategy, a homobifunctional linker,
dithiobis(succinimidyl propionate) (DSP), was used for
electrode modification and for antibody immobilization.
DSP is one of the thiolated precursors known to form self-
assembled monolayers on gold surfaces. It is also used to
attach recognition bioelements to gold nanoparticles. First,
its disulfide linkage undergoes direct reductive chemisorp-
tion resulting in a self-assembled monolayer on the gold
support. This leaves the preactivated NHS group ready to
react with available primary amines (for example lysines) on
a protein of choice. In our case, the surface amine groups on
the antibody proteins replaced the NHS groups on the DSP,
forming covalent linkages with the gold surface. Similar to
the cysteamine case, covalent immobilization of anti-
FLRhop-3 antibodies on DSP-modified electrode results in
a reduced current, indicating successful immobilization of
antibody proteins. Incubation of the anti-FLRhop-3-modi-
fied electrode in a solution containing Rhop-3 proteins
(60 μg mL 1) at 37 °C results in a further decrease in
current, consistent with limited access of the ferricyanide
reporting redox probe to the electrode surface. Binding of
the target Rhop-3 protein limits this access and these results
indicate positive recognition and binding of Rhop-3 proteins
by the immobilized specific antibody. Figure 3 shows the
differential voltammogram representing the current differ-
ence between the consecutive steps of antibody immobili-
zation and antigen (Rhop-3) recognition. Although the
decrease in current on Rhop-3 binding was small, it is
significant, and it is much larger than the decrease obtained
with cysteamine–glutaraldehyde immobilization.
It is important to report that the relative current decrease
on exposure to Rhop-3 solution was also accompanied by a
Fig. 2 Cyclic voltammetry response of a gold electrode modified with
cysteamine glutaraldehyde (blue trace) followed by anti FLRhop 3
immobilization (green trace). Electrode response on addition of
Rhop 3 (60 μg mL 1) (red trace). Scan rate used is 0.1 Vs 1
Fig. 3 Differential current response (i.e. response of antigen minus
response of antibody). Voltammetry recorded in the absence and pres
ence of 60 μg mL 1 Rhop 3 on a DSP antibody modified gold elec
trode. Scan rate used is 0.1 Vs 1. Control signal was recorded in the
presence of 60 μg mL 1 chicken ovalbumin in lieu of the Rhop 3 target
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slight increase in peak-to-peak potential difference (~33 mV
increase in ΔEp measured by cyclic voltammetry). TheΔEp
change is also an indication of binding of Rhop-3 targets on
the antibody-modified interface. The increase of ΔEp indi-
cates that the rate of electron transfer to the redox probe
becomes relatively sluggish [21]. The compromised
electron-transfer kinetics may be the result of a modified
microenvironment on the electrode surface which, in part,
may alter the needed ion transfers to buried sites where the
redox reporter exchanges an electron with the underlying
electrode. Although the results of this initial work demon-
strate the possibility of preparation of an immunosensor that
can recognize Rhop-3 malaria antigen, systematic and de-
tailed studies of stability, reproducibility, and reusability
were not carried out at this feasibility stage. One reason is
that the method of detection based on redox probe access is
not robust and was used for demonstration purposes only for
this early proof of principle.
In terms of controls, we tested the response of our
immunosensor to chicken ovalbumin, to contrast it with
the specific recognition of Rhop-3 proteins. Figure 3
shows the differential response obtained when the antibody-
modified electrode was exposed to a solution of chicken
ovalbumin for 1 h, in lieu of the target Rhop-3 antigen.
Figure 3 shows that the peak current obtained with
60 μg mL 1 chicken ovalbumin is much smaller than that
obtained with the target Rhop-3 proteins, and indicates that
our electrochemical immunosensor enables specific recogni-
tion of Rhop-3 proteins.
Although this communication and the detection strat-
egy relying on access of ferricyanide to the electrode
surface provides a proof of principle for our immuno-
sensor based on Rhop-3 antibody, other known detec-
tion strategies, based, for instance, on secondary
enzymatic reactions, can be coupled to our immobiliza-
tion method and may give better detection sensitivity. In
this regard, and in an effort to increase the sensitivity of
our electrochemical immunosensor, we are now investi-
gating other methods, including the use of nanostruc-
tured surfaces to enhance the capture of the antigen
from test samples and the use of enzyme-labeled sec-
ondary antibodies to enhance signal transduction.
Conclusions
This work is a first attempt to generate an immunosensor
that targets the Rhop-3 malaria protein. We successfully
immobilized antibodies against recombinant full length
Rhop-3 protein to cysteamine-modified and DSP-modified
gold electrodes. Rhop-3 antigen detection was achieved,
with optimum antigen binding at 37 °C. Detection of
PfHRP2 in clinical samples has been shown to depend on
parasite density and concentration of PfHRP2 in blood.
In future studies, we will evaluate the concentration
correlation with parasite densities using our sensor,
which targets the Rhop-3 antigen. Conserved P. falcipa
rum blood stage antigens that can be identified in blood
and other patient samples are alternative choices for
malaria diagnostic biomarkers. After antibody immobili-
zation, antigen detection is a one-step process. A simple
and sensitive procedure for detection of antigen in pa-
tient samples will enable accurate malaria diagnosis and
efficient monitoring of malaria drug treatment. Further
development of the Rhop-3 immunosensor includes op-
timizing antigen and antibody concentrations to improve
the sensitivity of antigen detection. We are also investi-
gating other methods, including the use of nanostruc-
tured surfaces to enhance antigen capture from the bulk
of the sample coupled with use of enzyme-labeled sec-
ondary antibodies to enhance signal transduction.
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